What was the highest reduction in the maximum retail price reported for an anti-cancer medicine?
- A.50 per cent
- B.67.45 per cent
- C.85 per cent
- D.96.45 per cent
Correct answer
Explanation
The correct answer is 96.45 per cent, the steepest cut in a maximum retail price reported to the National Pharmaceutical Pricing Authority after it capped trade margins on anti-cancer drugs. Option A, fifty per cent, is the mark that separates the 679 brands whose prices were reported as falling by more than half from the rest, so it is a threshold in the same data and not the highest cut. Option C, eighty-five per cent, mirrors the count of eighty-five pharmaceutical companies that filed revised prices by 8 November 2026 and is not a price reduction at all. Option B is a figure that appears nowhere in the decision. The maximum reduction of 96.45 per cent, together with the cuts in the other brands, produces the expected annual saving of Rs 3,540.38 crore for consumers.
Read the full article: NPPA Cuts MRP of 1,364 Anti-Cancer Formulations from 9 November
Practice Questions
Revised maximum retail prices have been reported for how many anti-cancer formulations, which came into effect on 9 November 2026?
- A.137
- B.1,364
- C.121
- D.679
Show answer
As on 8 November 2026, eighty-five pharmaceutical companies had reported revised maximum retail prices for 1,364 anti-cancer formulations, and those prices came into force on 9 November 2026.
Read the full explanation →Which authority capped the trade margins on the maximum retail price of 137 anti-cancer drugs?
- A.Central Drugs Standard Control Organisation
- B.Food Safety and Standards Authority of India
- C.National Pharmaceutical Pricing Authority
- D.Directorate General of Health Services
Show answer
The NPPA works under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, and it is the body that capped trade margins on the retail prices of 137 anti-cancer drugs, with the revised rates applying from 9 November 2026.
Read the full explanation →What is the estimated annual saving to consumers from the revised prices of anti-cancer medicines?
- A.Rs 1,364 crore
- B.Rs 2,540.38 crore
- C.Rs 3,540.38 crore
- D.Rs 679 crore
Show answer
That is the yearly saving the National Pharmaceutical Pricing Authority expects consumers to make once the reduced maximum retail prices of the anti-cancer formulations are in force from 9 November 2026.
Read the full explanation →What was the theme of the 14th India Chem 2026 held in Mumbai?
- A.Advantage Bharat: An Emerging Global Chemicals Hub
- B.Chemicals for a Viksit Bharat
- C.Green Chemistry, Green Growth
- D.Make in India, Mix in India
Show answer
The 14th edition of India Chem was organised in Mumbai from 22 to 24 October 2026 as a three-day event aimed at drawing investment and promoting sustainable growth in chemicals and petrochemicals.
Read the full explanation →Which of the following is NOT one of India's three operational Petroleum, Chemicals and Petrochemicals Investment Regions?
- A.Dahej in Gujarat
- B.Paradeep in Odisha
- C.Visakhapatnam-Kakinada in Andhra Pradesh
- D.Haldia in West Bengal
Show answer
India has three operational PCPIRs: Dahej in Gujarat, Visakhapatnam-Kakinada in Andhra Pradesh and Paradeep in Odisha. Haldia is not among them, so option D is the exception.
Read the full explanation →